Abstract Objective The influence of vitamin supplements on breast cancer risk is unclear and the interactive effects of dietary and supplemental sources are unknown. This study investigated (1) the association between selfreported vitamin supplement use (multivitamin, A, B, C, and E) and breast cancer and (2) the combined effect of vitamin supplements in relation to dietary vitamin intakes on breast cancer risk. Methods The Shanghai Breast Cancer Study was a population-based case-control study conducted in Shanghai in 1996-1998 (Phase I) and 2002 -2004 . Participants were aged 25-64 (Phase I) and 20-70 years (Phase II). The analyses included 3,454 incident breast cancer cases and 3,474 controls. Unconditional logistic regression models were used to determine adjusted odds ratios (ORs) for breast cancer risk associated with vitamin supplement use. Results Overall, breast cancer risk was not related to any vitamin supplement intake.
Introduction
Due to their importance in biological functions, vitamins have been extensively studied over the past few decades for their relationship with a wide-variety of health outcomes, including breast cancer [1] [2] [3] . Vitamins are hypothesized to affect breast cancer risk through an assortment of mechanisms, including their antioxidant capabilities against freeradical induced DNA damage, maintenance of cellular integrity, coenzyme, immune, and reproductive system functions [4] [5] [6] . However, despite laboratory-based findings [7] [8] [9] , epidemiological studies have been unable to provide unequivocal evidence for a preventive effect of both dietary and supplemental vitamin intakes in preventing breast cancer for most common vitamins [10] [11] [12] [13] [14] [15] [16] .
Vitamin supplements, including vitamins A, C, E and B, first became available in the early 1930s. Today, these supplements often contain substantially higher concentrations of vitamins than are available from typical dietary sources and populations in many countries have extensive availability to these preparations [1, 2, 17, 18] . However, despite their prevalent use, few studies have specifically evaluated use of specific vitamin supplements (multivitamin, A, C, B and E) with breast cancer risk. In this study, we examine the relationship between breast cancer risk and vitamin supplement use in a large population-based casecontrol study in urban Shanghai, China.
Methods

Study population
The Shanghai Breast Cancer Study is a large populationbased case-control study conducted in Shanghai, China August 1996-March 1998 (Phase I) and April 2002-February 2005 (Phase II). Detailed methods have been published elsewhere [19] . Cases were identified by a rapid case-ascertainment system, supplemented by the population-based Shanghai Cancer Registry and diagnoses were confirmed by medical record review. Participants were excluded if they were not permanent residents of urban Shanghai or if they had a prior history of cancer.
Controls were randomly selected from female permanent residents using the Shanghai Resident Registry, a population registry containing address and demographic information for all residents of urban Shanghai, and were frequency matched on age (5-year intervals) to the expected age distribution of the cases in a 1:1 ratio. A total of 1,455 (response rate: 91.1%) and 1,999 (83.7%) cases and 1,556 (90.3%) and 1,918 (70.4%) controls were recruited in Phase I and II respectively, comprising a total of 3,454 cases and 3,474 controls for this analysis. The study protocols were approved by the Institutional Review Boards of all institutes involved in the study, and written, informed consent was obtained from all study participants.
Data collection
Information on demographic characteristics, personal and first-degree family history of cancer, other diseases, and various behavioral and dietary habits and vitamin supplement use were collected by in-person interviews conducted by trained staff. With few exceptions, the questionnaires from both phases were identical. Usual adult dietary intake was collected using a comprehensive food frequency questionnaire (FFQ) that covers about [85% of commonly consumed foods in Shanghai, China. The FFQ from Phase II included ten additional food items and use of folic acid supplement. Data were collected using the following definitions: education was ascertained as the number of years of schooling completed including post-secondary education, menopausal women had ceased menstruation for at least 12 months excluding lapses caused by pregnancy or breastfeeding, and exercise participation was defined as self-reported participation in exercise or sports in the past 10 years. The question on exercise participation was validated in our previous studies that indicated the physical activity questionnaire is a reproducible and a valid measure of exercise behavior among Chinese women [20] . Anthropometric measurements were completed by trained interviewers according to standard protocols for current weight, circumferences of the waist and hips, and sitting and standing heights. Waist-to-hip ratio (WHR) and body mass index (BMI, kg/m 2 ) were calculated from these measurements.
Participants in both phases were asked whether they had ever taken any vitamin supplement at least three times per week for more than 2 months continuously per year during the 5-year period prior to breast cancer diagnosis (cases) or enrollment (controls). These included multivitamin, vitamins A, B, C, E, and, for Phase II only, folic acid. If participants had ever taken any vitamin supplement and for each supplement they used, participants were asked for how many months in total they had used the supplement (duration), and during those months how many times per day or week they used them (frequency). Vitamin supplement intake frequency was categorized as less than or equal to once daily and greater than once daily per week and duration was categorized as less than 1 year, 1-2 years, and equal to or more than 3 years. Information regarding the specific brand, composition and dosage of vitamin supplements was not available. Total dietary intakes of vitamins A, B (a composite of B1, B2, niacin, and B12), E, and C were derived from the FFQ and the Chinese and USDA food composition tables [21, 22] . In the validation study, correlations for these nutrients ranged from 0.43 to 0.59 comparing 24 h recalls with the FFQ [23] .
Statistical analysis
Statistical tests were based on a two-sided probability with a significance level of 0.05. Odds ratios (OR) were used to measure the association between breast cancer with various exposures. Unconditional logistic regression (LR) was used to estimate ORs and 95% confidence intervals (CI), with adjustment for breast cancer risk factors identified in this population. The latter included age (continuous), education, age at menarche (£12, 13-14, 15-16, and Quartile distributions among combined controls (both phases) were used to categorize BMI and WHR.
For our analyses we grouped cases and controls into six groups based on their supplement use patterns: any vitamin supplement users, multivitamin only users and specific supplement users (vitamins A, B, C, and E) with multivitamins, which is similar to previously reported studies [3, 24] . To evaluate the impact of vitamin supplement use on breast cancer risk in the context of dietary status, we conducted stratified analyses by median or tertile dietary intakes of specific vitamins corresponding to the vitamin supplements. Median and tertile distributions were determined using the combined controls (both phases). For B vitamins, the distribution was based on a summary score created by summing the quartile score of intakes for B1, B2, niacin, and B12, which were the standard B vitamin components during the period of the study. Tests for trend were performed by entering the categorical variables as continuous parameters in the model. Tests for interaction were performed using the log likelihood test. All data management and statistical analyses were performed using SAS version 9.1 (SAS Institute, Cary, NC).
Results
Characteristics of the participants of the two study phases are presented in Table 1 . The average age was 47.9 and 50.8 for cases and 47.2 and 51.6 years for controls for Phase I and Phase II, respectively. In general, participants of the two phases were comparable with the exception that Phase II subjects were slightly older and more frequently post-menopausal as a result of wider age eligibility. As compared to controls, cases were more likely to have higher educational attainment, an earlier age at menarch (P \ 0.05 for both phases), later age at first birth or menopause, a family history of breast cancer among firstdegree relatives, a personal history of breast fibroadenoma, and a higher red meat intake. They were also more likely to be nulliparous and overweight or obese and less likely to have breast fed or exercised regularly (P £ 0.001 for both phases). There were no differences in alcohol use and intakes of total energy, or vegetables and fruits between cases and controls in both phases.
Characteristics of vitamin supplement users and nonusers were compared within the control populations ( Table 2 ). The proportion of women who took supplements in Phase II compared to Phase I was greater (24.8% vs. 14.5%). Among cases, this difference was even larger; in Phase I only 11.5% and in Phase II over 26.5% were users (data not shown in table).
Supplement users had higher educational attainment than non-users (P \ 0.0001 for both phases). They also were more likely to have an earlier age at menarche, more likely to be post-menopausal, more often engaged in regular exercises in the past 10 years, and more likely to have a lower BMI or a lower WHR, and a personal history of fibroadenoma in both phases. In Phase I, users were also more likely to be older and less likely to be parous. In comparison with Phase II non-users, users were more likely to have higher vegetable and fruit intake. Neither energy intake nor meat intake were statistically significantly different between users and non-users in either study phase.
Presented in Table 3 are comparisons of cases and controls for use of specific vitamin supplements. Among users, multivitamins were the most-used supplement on a daily basis. When use of multivitamins or use of specific vitamin supplements were evaluated, we did not find any statistically significant associations between any use, duration, or frequency of use in this population. We analyzed the associations between vitamin supplement intake and breast cancer for each phase of study. Results were similar for both phases so only the results from the combined analyses are presented. Additionally, results from analyses stratified by menopausal status did not appreciably differ from unstratified analyses as reported above (data not shown in table).
To evaluate the association between use of individual vitamin supplements in the context of dietary intake for these same vitamins, we stratified all analyses by low and high dietary intakes (Table 4) . Use of vitamin A or vitamin C supplements was not associated with risk for breast cancer regardless of dietary intake of the same vitamins. Among those with high dietary intake of B vitamins, there was an increased risk associated with frequent intake (OR = 1.4; 95% CI: 0.9-2.1) that was not statistically significant. Among those with low intake, there was a modest, but statistically insignificant, decreased risk of breast cancer associated with B supplement use. Among women with low dietary intake of vitamin E, use of any vitamin E supplement was associated with a decreased risk for breast cancer (OR = 0.8; 95% CI, 0.6-1.0). Longer duration of use of vitamin E supplement may confer additional protection (P trend = 0.03). Any use of supplements was also evaluated by tertiles of dietary intake (data not shown). An increased risk of breast cancer was observed with use of a vitamin B supplement among those who had the highest dietary B vitamin intake and a decreased risk was observed for those with the lowest intake (P interaction = 0.01).
Discussion
In Shanghai, the proportion of women who took supplements in Phase II compared to Phase I was substantially greater. In this case-control study, we found little evidence that overall use of vitamin supplements was associated with breast cancer risk. However, we did observe a statistically significant decreased risk of breast cancer associated with use of vitamins E and B among those with low dietary intake. We also found that use of a vitamin B supplement was associated with an increased risk among those with high dietary intake. Breast cancer occurs as a culmination of a multi-step process. Vitamins, through their effect in many cellular functions, may potentially affect breast carcinogenesis [7, 25] . The B family of vitamins, including B1 (thiamine), B2 (riboflavin), B3 (niacin), B6 (pyridoxine), B12 (cyanocobalamin) and folate, function in one-carbon metabolism, oxidative stress pathways, the immune and nervous systems, and cell growth and division [2, 26, 27] .
Antioxidants, including vitamins C, E, and carotenoids are important in the defense against oxidative damage, such as DNA damage, from free radicals [5, 28, 29] . Although the mechanisms are not clearly understood, oxidative damage is thought to occur during the promotional stage of carcinogenesis. For this reason, antioxidants may cause regression of premalignant lesions or inhibit their development into cancer [30] . These antioxidants also have other important roles in cellular processes. Vitamin C (ascorbic acid) is essential for metabolic reactions in the body [29, 31] . Vitamin A (retinol) is needed for cell differentiation, normal functioning of the immune or reproductive systems, and vision [8, 29, 32] . The lipid-soluble Vitamin E also helps immune response, maintenance of cell membranes, anti-inflammatory reaction and DNA synthesis. In animal models, Vitamin E may counteract cellular proliferation and protect against carcinogen-induced mammary tumor development [28, 33] . However, there are other reports that this protection may be affected by the presence of other dietary components, such as polyunsaturated fatty acids [2, 34] . Overall, the results of this study support previous epidemiological findings in which vitamin supplementation alone does not substantially affect the risk of breast cancer [24, 35, 36] . In this study vitamin A intake, from both dietary intake and supplements, was not associated with breast cancer risk or incidence as seen in several previous studies [16, 37, 38] . However, some other studies did find significant inverse [39, 40] or borderline inverse associations [10, 12, 41] . One study found use of a vitamin A supplement was associated with a decreased risk among those with the lowest intake [42] . Likewise, vitamin C intake, has also had conflicting reports of both null and non-significant inverse associations with breast cancer risk [37, 41, 43] . However, several case-control studies [44, 45] and one meta-analysis [15] reported a significant inverse association for vitamin C intake. In our study, we found breast cancer risk to be associated with use of a B-vitamin supplement varied according to dietary intake levels. In studies which have evaluated use of supplemental B vitamins, supplemental use has not been associated with risk of breast cancer [46, 47] , although dietary intake of some B vitamins (B12, B6 and folate) [48, 49] , and adequate levels of serum B12 and folate have been associated with a decreased risk in other studies [44, 49] including in a previous report from our own study [23] . There have also been recent reports that folic acid, which was not evaluated in this present study, and possibly other B vitamins, may have dual effects on breast cancer [50, 51] . In the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening trial, folic acid supplementation was associated with an increased risk of breast cancer [46] .
In the Women's Health Study, a 10-year randomized trial of a vitamin E supplement [36] , and in both the Nurses' Health Study and the Iowa Women's Health study, intake of vitamin E alone was not sufficient to protect against breast cancer [13, 52] . In contrast to some cohort [35, 37, 41, 52] and case control studies [10, 11, 48, 53] of dietary intake or supplemental intakes only [12, 24] , we found that vitamin E supplementation was associated with a decreased risk of breast cancer among women who had lower dietary intakes. It has been previously suggested that the effect of supplemental vitamin E intake on breast cancer risk may be dependent upon the dietary intake level within the population or possibly food sources [29, 40, 54] . In our population, median dietary intake is below recommended levels and lower than many of the previous studies [2, 29] . Thus, it is possible that use of a vitamin E supplement may confer protection against breast cancer among women with insufficient dietary Vitamin E intake. In our study, an association between vitamin supplement use and breast cancer risk could have been obscured by the short duration of use (etiological window) or the use of supplements among those at high risk. In many populations, vitamin supplement use is a marker of a healthy lifestyle [55, 56] . In our study population, use of vitamin supplements was associated with income and education, but not related to dietary intake. We carefully controlled for many of these factors in our statistical analyses, although the possibility of residual confounding remains. As in all case-control studies, the possibility of recall bias must also be considered. However, nearly all users reported taking the vitamin supplement at least once daily indicating that, in this population of users, vitamin supplement use is a frequent habit which may facilitate recall for both cases and controls. We also evaluated vitamin supplement use that lasted at least one year and found similar results. Lack of information about composition of the vitamin supplements, particularly B vitamins, and specific dosages of vitamins prevented in-depth analysis and may also explain differences between our findings and previous studies.
This study has several strengths. This is a populationbased study with a large sample size and high response rates. We were able to evaluate both the frequency and duration of supplement use, and to evaluate it in the context of dietary intake. We were also able to evaluate both preand post-menopausal breast cancer risk. Unlike populations in many Western countries, the Chinese food supply is not fortified with vitamins, which enabled us to investigate the effect of vitamin preparations.
In summary, this large population-based breast cancer case-control study does not support a strong role for vitamin supplements in the prevention of breast cancer among populations with sufficient dietary intake of vitamins. However, supplemental use of vitamins E and B may be inversely associated with breast cancer risk among women with low dietary intake of these vitamins.
